RW Stidham, K Takenaka - Gastroenterology, 2022 - pathwaysgi.com
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel disease (IBD). Advances in the machine learning …
RW Stidham, K Takenaka - Gastroenterology, 2022 - pgi.wagdesign.com
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel disease (IBD). Advances in the machine learning …
RW Stidham, K Takenaka - Gastroenterology, 2022 - europepmc.org
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel diseases (IBD). Advances in the machine learning …
RW Stidham, K Takenaka - Gastroenterology, 2022 - gastrojournal.org
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel disease (IBD). Advances in the machine learning …
RW Stidham, K Takenaka - Gastroenterology, 2022 - pubmed.ncbi.nlm.nih.gov
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel disease (IBD). Advances in the machine learning …
RW Stidham, K Takenaka - Gastroenterology, 2022 - ncbi.nlm.nih.gov
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel diseases (IBD). Advances in the machine learning …
RW Stidham, K Takenaka - Gastroenterology, 2022 - cir.nii.ac.jp
Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …